Ruxience 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB26FNNVX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,074
Award facts
- Contract value 100% obligated
- $5,073.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ruxience 500 mg/50 ml vials, a biosimilar medication used in cancer treatment and other therapeutic applications. This $5,073.74 firm fixed-price delivery order, with a completion date of November 5, 2025, represents a routine pharmaceutical procurement executed under a competitive, non-set-aside process. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The DLA's Troop Support Medical program relies on contractors like AmerisourceBergen to maintain pharmaceutical supply chain resilience for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA currently planning next-generation pharmaceutical prime vendor contracts that may involve multiple regional awards across different contractors.
Quick answers
Who was awarded contract SPE2DB26FNNVX?
SPE2DB26FNNVX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FNNVX worth?
The government has obligated $5,074 on SPE2DB26FNNVX.
Is contract SPE2DB26FNNVX an order under another contract?
Yes. SPE2DB26FNNVX is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNVX competed?
The extent of competition for SPE2DB26FNNVX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award